Synergy Pharma (SGYP) Now Half Enrolled in Plecanatide Phase 2b
Tweet Send to a Friend
Synergy Pharmaceuticals Inc. (Nasdaq: SGYP) announced that it has reached the halfway mark for total enrollment in its ongoing plecanatide ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE